Archives: 2024-06-22

Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients

Even though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory failure or thromboembolism. It is well-known that factors such as age and underlying medical conditions like diabetes or immunodeficiencies increase vulnerability to severe COVID-19.

Read More


Electrolytes can give the body a charge, but try not to overdo it : American Heart Association indications

You might think electrolytes are some kind of lab-made superfuel for elite athletes and those who want to be like them. Electrolytes are indeed powerful, and in some circumstances, your body might benefit from a boost. But like comic book heroes with mild-mannered alter egos, they might already be hanging around in your life by

Read More


FDA panel recommends updating the Covid vaccines for the fall to target JN.1 strain

FDA advisers say new shots can target more recent SARS-CoV-2 variants SARS-CoV-2 keeps evolving, and it’s time for COVID-19 vaccines to again follow suit, advisers to the U.S. Food and Drug Administration (FDA) agreed today. The panel voted unanimously in favor of updating the shots to more closely match virus strains now circulating. Although FDA

Read More


New Gene Therapy Trial Shows Restored Hearing and Speech in Children Born Deaf, Treated in Both Ears

Administering gene therapy in both ears of five children with DFNB9 led to additional benefits compared to previous trial, including sound source localization and hearing in noisy environments. Key Takeaways A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were treated in both ears. The

Read More


The Route Into the Cell Influences the Outcome of Sars-Cov-2 Infection

A surface protein helps viruses to enter cells. This has far-reaching consequences for the infection. How exactly do Sars-Cov-2 particles enter host cells? An international team led by Dr Richard Brown from Dr Daniel Todt’s Computational Virology group at the Department of Molecular and Medical Virology at Ruhr University Bochum, Germany, together with researchers from

Read More